These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20926799)

  • 1. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation.
    Ota N; Takase M; Uchiyama H; Olsen SK; Kanagawa O
    J Immunol; 2010 Nov; 185(10):6041-8. PubMed ID: 20926799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.
    Mortier E; Advincula R; Kim L; Chmura S; Barrera J; Reizis B; Malynn BA; Ma A
    Immunity; 2009 Nov; 31(5):811-22. PubMed ID: 19913445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation.
    Perdreau H; Mortier E; Bouchaud G; Solé V; Boublik Y; Plet A; Jacques Y
    Eur Cytokine Netw; 2010 Dec; 21(4):297-307. PubMed ID: 21078585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different NK cell developmental events require different levels of IL-15 trans-presentation.
    Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
    J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
    Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both?
    Schluns KS; Stoklasek T; Lefrançois L
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1567-71. PubMed ID: 15896666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
    Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
    J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
    Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice.
    Hattori M; Okazaki H; Ishida Y; Onuma M; Kano S; Honjo T; Minato N
    J Immunol; 1990 May; 144(10):3809-15. PubMed ID: 2332632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
    Faller E; Kakal J; Kumar R; Macpherson P
    Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice.
    Asano M; Ishida Y; Sabe H; Kondo M; Sugamura K; Honjo T
    J Immunol; 1994 Dec; 153(12):5373-81. PubMed ID: 7989743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
    Lu J; Giuntoli RL; Omiya R; Kobayashi H; Kennedy R; Celis E
    Clin Cancer Res; 2002 Dec; 8(12):3877-84. PubMed ID: 12473603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
    Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
    J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.